iShares Health Innovation Active ETF Rating $26.30 +0.64 (+2.49%) As of 01/21/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHeadlinesHoldingsRatings iShares Health Innovation Active ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BMED Aggregate RatingModerate Buy 2.75Holdings in BMED have an aggregate rating of Moderate Buy based on 745 analyst ratings issued in the past year covering 43 companies (67.5% of the portfolio).BMED Aggregate Price Target$26.30High Prediction$26.30Average Prediction$26.30Low Prediction$26.30Holdings in BMED have an aggregate price target of $26.30 and a range of $26.30 to $26.30 covering 43 companies (67.5% of the portfolio).BMED Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy6 Buy rating(s)Moderate Buy30 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Health Innovation Active ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 43 BMED Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.46%ISRGIntuitive Surgical$604.12+1.9%4.6185 of 5 stars2.74$554.17 -8.3%19Upcoming EarningsNews CoveragePositive News5.06%BSXBoston Scientific$100.90+2.3%4.6653 of 5 stars2.96$97.26 -3.6%23Upcoming EarningsPositive News3.73%ARGXargenx$647.39+1.1%2.3342 of 5 stars2.86$658.39 1.7%22Gap Up3.05%GILDGilead Sciences$92.96+1.2%4.5634 of 5 stars2.70$97.96 5.4%27Analyst RevisionPositive NewsHigh Trading Volume2.17%ABTAbbott Laboratories$116.78+2.9%4.9047 of 5 stars2.73$131.93 13.0%15Analyst ForecastPositive News2.13%RGENRepligen$167.92+4.6%3.7258 of 5 stars2.62$185.20 10.3%13High Trading Volume2.11%TECHBio-Techne$78.75+3.9%4.1199 of 5 stars2.63$82.00 4.1%8News Coverage2.07%WATWaters$413.63+2.4%4.4072 of 5 stars2.33$384.71 -7.0%15High Trading Volume2.02%MDTMedtronic$88.35+0.3%4.9404 of 5 stars2.41$95.00 7.5%17News CoveragePositive News2.02%SRPTSarepta Therapeutics$116.79-1.0%4.9641 of 5 stars2.91$178.71 53.0%22Analyst Revision1.98%BMYBristol-Myers Squibb$57.01+1.3%4.919 of 5 stars2.29$56.27 -1.3%21Analyst RevisionPositive News1.89%NBIXNeurocrine Biosciences$145.88+1.8%4.9124 of 5 stars2.83$164.81 13.0%23Analyst RevisionNews Coverage1.86%NTRANatera$167.46+5.7%2.3919 of 5 stars3.00$160.63 -4.1%16High Trading Volume1.81%DHRDanaher$244.18+2.4%4.883 of 5 stars2.75$285.55 16.9%20Upcoming EarningsAnalyst ForecastPositive News1.72%PODDInsulet$276.08+0.1%4.4241 of 5 stars2.81$272.81 -1.2%16Positive News1.67%ABBVAbbVie$172.41+0.5%4.9964 of 5 stars2.88$205.50 19.2%24Analyst RevisionPositive News1.58%EXASExact Sciences$54.26+4.9%4.8179 of 5 stars2.94$72.94 34.4%18Analyst RevisionNews Coverage1.47%TMOThermo Fisher Scientific$572.85+2.4%4.9741 of 5 stars2.86$648.95 13.3%22News CoveragePositive News1.46%WSTWest Pharmaceutical Services$344.87+2.5%4.6378 of 5 stars2.83$430.20 24.7%6Positive News1.38%DXCMDexCom$86.32+2.3%4.9706 of 5 stars2.89$99.29 15.0%18Gap Up1.15%RYTMRhythm Pharmaceuticals$57.52+5.5%4.2106 of 5 stars2.91$68.09 18.4%11High Trading Volume1.09%EWEdwards Lifesciences$69.94+0.2%4.369 of 5 stars2.38$78.48 12.2%261.08%GHGuardant Health$45.13+23.1%3.4249 of 5 stars3.00$40.60 -10.0%15News CoverageGap UpHigh Trading Volume1.08%AMGNAmgen$274.81+1.0%4.8903 of 5 stars2.44$314.91 14.6%27Analyst RevisionPositive News1.03%ALNYAlnylam Pharmaceuticals$264.99+7.6%4.4526 of 5 stars2.72$298.61 12.7%25Analyst ForecastGap Up1.01%AAgilent Technologies$152.61+3.6%4.2484 of 5 stars2.43$143.62 -5.9%14Positive News1.01%PENPenumbra$268.45+1.8%3.9725 of 5 stars2.81$261.36 -2.6%16Analyst ForecastNews CoverageGap Up1.00%QGENQiagen$47.54+3.4%3.594 of 5 stars2.56$51.50 8.3%9Gap UpHigh Trading Volume1.00%XENEXenon Pharmaceuticals$38.98+1.2%2.7705 of 5 stars3.13$56.00 43.7%8Positive News0.99%EXELExelixis$36.43+0.6%4.6946 of 5 stars2.53$35.50 -2.6%190.97%BPMCBlueprint Medicines$111.96+1.7%1.1311 of 5 stars2.65$122.72 9.6%20Gap Up0.90%LHLaboratory Co. of America$244.39+2.4%4.853 of 5 stars2.88$260.54 6.6%16Positive News0.88%UTHRUnited Therapeutics$367.97+2.5%4.926 of 5 stars2.73$378.36 2.8%15Positive NewsHigh Trading Volume0.79%BDXBecton, Dickinson and Company$240.19+1.2%4.8974 of 5 stars3.00$283.50 18.0%6Insider TradeAnalyst RevisionNews Coverage0.78%MRUSMerus$39.74+0.7%3.357 of 5 stars3.14$85.64 115.5%140.78%SYKStryker$395.86+3.2%4.8695 of 5 stars2.81$405.80 2.5%21Upcoming EarningsAnalyst DowngradePositive NewsHigh Trading Volume0.77%DNLIDenali Therapeutics$23.04+5.1%4.4155 of 5 stars2.93$38.91 68.9%14Short Interest ↑Analyst Revision0.77%BIIBBiogen$140.98+0.3%4.7341 of 5 stars2.43$230.00 63.1%280.77%IQVIQVIA$205.23+4.0%4.7741 of 5 stars2.90$255.71 24.6%21Analyst ForecastNews CoveragePositive News0.76%SNYSanofi$51.69+1.9%2.9174 of 5 stars3.00$57.50 11.2%30.76%PFEPfizer$26.63+1.2%4.9935 of 5 stars2.50$32.00 20.2%16Positive News0.73%HOLXHologic$70.37+0.9%4.9519 of 5 stars2.63$88.92 26.4%16Short Interest ↑Analyst Revision0.71%ILMNIllumina$141.31+3.4%4.5189 of 5 stars2.70$165.63 17.2%20Analyst Revision This page (NYSEARCA:BMED) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredThe Crypto Secret Wall Street Doesn’t Want You to KnowPotential $20-trillion opportunity? Put $500 into THIS AI Coin for 2025… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Health Innovation Active ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Health Innovation Active ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BMED Stock Alerts